日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A-site dependent metastable polar phases from polarization compatible octahedral rotations in perovskite AZrO(3) (A = Ca, Sr)

钙钛矿AZrO(3) (A = Ca, Sr)中极化兼容八面体旋转引起的A位依赖性亚稳极性相

Choi, Min Chul; Park, Se Young

Identification of Prognostic Biomarkers of Ovarian High-Grade Serous Carcinoma: A Preliminary Study Using Spatial Transcriptome Analysis and Multispectral Imaging

利用空间转录组分析和多光谱成像技术鉴定卵巢高级别浆液性癌的预后生物标志物:一项初步研究

Kang, Haeyoun; Joung, Je-Gun; Park, Hyun; Choi, Min Chul; Koh, Doohyun; Jeong, Ju-Yeon; Lee, Jimin; Kim, Sook-Young; Jung, Daun; Hwang, Sohyun; An, Hee Jung

Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor.

利用冷冻保存的人类肿瘤癌细胞建立患者来源细胞异种移植(PDCX)模型及其应用

Kim Ki Yeon, Lee Ji Min, Lee Eun Ji, Jung Daun, Goh Ah-Ra, Choi Min Chul, Jung Sang Geun, Park Hyun, Hwang Sohyun, Kang Haeyoun, An Hee Jung

Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines

子宫体癌临床实践指南:韩国妇科肿瘤学会指南更新

Hwang, Woo Yeon; Kim, Ju-Hyun; Noh, Joseph J; Baek, Min-Hyun; Choi, Min Chul; Lee, Yong Jae; Lee, Maria; Suh, Dong Hoon; Kim, Yong Beom; Kim, Dae-Yeon

Morbidity and Mortality Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer

卵巢癌细胞减灭术联合腹腔热灌注化疗后的发病率和死亡率结果

Kim, Migang; Lee, Yong Jae; Seon, Ki Eun; Kim, Sunghoon; Lee, Chan; Park, Hyun; Choi, Min Chul; Lee, Jung-Yun

From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps

从韩国妇科肿瘤协作组的成立到现在及未来发展方向

Min, Kyung-Jin; Kim, Nam Kyeong; Song, Jae-Yun; Choi, Min Chul; Lee, Shin Wha; Lee, Keun Ho; Kim, Min Kyu; Kang, Sokbom; Choi, Chel Hun; Lee, Jeong-Won; Lee, Eun-Ju; Eom, Keun-Yong; Kim, Sang Wun; Cho, Hanbyoul; Lee, Sun Joo; Lim, Myong Cheol; Bae, Jaeman; Yoo, Chong Woo; Kim, Kidong; Kim, Dae-Yeon; Lee, Chulmin; Ryu, Sang Young; Jeon, Seob; Kim, Jae-Weon; Nam, Byung-Ho; Kang, Soon-Beom; Kim, Kyung Tae; Nam, Joo-Hyun; Kim, Byoung-Gie; Kim, Yong-Man; Kim, Jae-Hoon

Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement

韩国子宫体癌诊疗实践指南:韩国妇科肿瘤学会共识声明

Kim, Ju-Hyun; Kim, Dae-Yeon; Kim, Junhwan; Noh, Joseph J; Hwang, Woo Yeon; Baek, Min-Hyun; Choi, Min Chul; Joo, Won Duk; Lee, Yong Jae; Suh, Dong Hoon; Kim, Yong Beom

Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy

对接受过新辅助化疗的晚期卵巢癌患者,在间隔性细胞减灭术后进行腹腔热灌注化疗

Lee, Jung-Yun; Lee, Yong Jae; Son, Joo-Hyuk; Kim, Sunghoon; Choi, Min Chul; Suh, Dong Hoon; Song, Jae-Yun; Hong, Dae Gy; Kim, Mi Kyung; Kim, Jae-Hoon; Chang, Suk-Joon

Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers

错配修复缺陷/高微卫星不稳定性发生率及其作为妇科肿瘤免疫检查点抑制剂疗效预测生物标志物的作用

Noh, Joseph J; Kim, Min Kyu; Choi, Min Chul; Lee, Jeong-Won; Park, Hyun; Jung, Sang Geun; Joo, Won Duk; Song, Seung Hun; Lee, Chan

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial

一项针对既往接受过PARP抑制剂治疗的铂敏感复发性卵巢癌患者的单臂II期研究,评估尼拉帕尼联合贝伐珠单抗维持治疗的疗效:韩国妇科肿瘤协作组(KGOG 3056)/NIRVANA-R试验

Park, Junsik; Lim, Myong Cheol; Lee, Jae-Kwan; Jeong, Dae Hoon; Kim, Se Ik; Choi, Min Chul; Kim, Byoung-Gie; Lee, Jung-Yun